Industry Developments
Israel
Leading generic drugmaker Teva has posted a strong set of financial results for Q210, with sales increasing by 11.76% to US$3.8bn from US$3.4bn in Q209. Operating profit figures for...
2010-07-28Syria
BMI view: Syria's pharmaceutical market is a small but underappreciated opportunity for multinational drugmakers. Sales of pharmaceuticals in Syria will increase from SYP15.4bn (US$336mn)...
2010-07-23Namibia
The Development Bank of Namibia has announced the approval of 34 projects worth NAD123.5mn (US$16.65mn) and expected to create 449 permanent and 538 temporary jobs. The round of loan...
2010-07-23Uganda
BMI View: The Ugandan government has reduced the country's health budget for 2010/11 by 14%. BMI believes this will lead to further delays in the implementation of Village Health Teams...
2010-07-20Nigeria
In 2009, pharmaceutical expenditure in Nigeria reached NGN89.74bn (US$0.600bn) and BMI expects spending on medicines to reach NGN103.21bn (US$0.693bn) in 2010 - a 15.0% increase in...
2010-07-14Kenya
Kenya, as with other markets in the region, can offer drugmakers numerous benefits including access to large, treatment-naïve populations as a result of underdeveloped healthcare systems....
2010-07-13In BMI's Q410 Pharmaceuticals & Healthcare Business Environment Ratings (BERs), the Middle East & Africa region scored a total of 45.40 out of a possible 100. Despite scoring...
2010-07-12Zambia
The Zambian government has renewed its healthcare infrastructure focused partnership (ORET-Zambia) with the Dutch government and Netherlands-based company Royal Philips Electronics,...
2010-07-06
